Reirradiation of recurrent breast cancer with and without concurrent chemotherapy
<p>Abstract</p> <p>Background</p> <p>Treatment options for loco-regional recurrent breast cancer after previous irradiation are limited. The efficacy of chemotherapy might be hampered because of impaired tissue perfusion in preirradiated tissue. Thus, mastectomy or loca...
Main Authors: | Kretschmer Matthias, Wenzel Claudia, Petersen Cordula, Dahle Jörg, Würschmidt Florian, Bastian Christoph |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-09-01
|
Series: | Radiation Oncology |
Online Access: | http://www.ro-journal.com/content/3/1/28 |
Similar Items
-
Reirradiation for Locoregional Recurrent Breast Cancer
by: Sayeh Fattahi, BS, et al.
Published: (2021-01-01) -
Proton Reirradiation for Locoregionally Recurrent Breast Cancer
by: Michael J. LaRiviere, MD, et al.
Published: (2021-07-01) -
Proton Reirradiation for High-Risk Recurrent or New Primary Breast Cancer
by: Molly A. Chakraborty, et al.
Published: (2023-12-01) -
Adrenocorticotropic Hormone Secreting Pituitary Carcinoma: Rare, Durable Response to Concurrent Chemotherapy and Reirradiation With a Review of the Literature
by: Megan Orr, MD, et al.
Published: (2022-03-01) -
Hepatic Reirradiation for Patients with Recurrent Hepatocellular Carcinoma
by: Yaoru Huang, et al.
Published: (2021-02-01)